CRCdx® RAS Mutation Detection

FDA-approved real-time PCR-based companion diagnostic for the detection of KRAS and NRAS mutations in colorectal cancer to support informed treatment decisions

Benchbot® 4800

​Streamline Your Workflow: From Sample to PCR Plate in Four Simple Steps

NPM1 One-Step MRD Kit

Highly sensitive assay detects NPM1 mutations at a 0.001% sensitivity level, providing quantitative MRD assessment.

Automation

Reagents

Software

Uncompromising
Quality & Support

All EntroGen products are manufactured in accordance with ISO 13485 standards.

Learn More

Join Us at World CB & CDx Summit

EntroGen is honored to participate in the 15th World Clinical Biomarkers & Companion Diagnostics Summit in Boston, taking place September 22-25. Dr. Gary Potikyan, EntroGen’s Chief Science Officer, will be a featured speaker. Dr. Potikyan will present “World-Wide...
Read More

2025 Great Lakes Genomic Conference

EntroGen is pleased to announce its participation in the 2025 Great Lakes Genomic Conference (GLGC), taking place on Friday, May 16, 2025, at the Peter Gilgan Centre for Research and Learning in Toronto, Ontario. As part of our ongoing commitment to advancing...
Read More

EntroGen Receives CMS Coverage for CRCdx® RAS Mutation Detection Kit

Apr 28, 2025 – EntroGen announced today that its CRCdx® RAS Mutation Detection Kit has received national coverage from the US Centers for Medicare & Medicaid Services (CMS).

Read More

EntroGen Newsletter

Receive quarterly updates on EntroGen news and products.

Subscribe now

Get in touch with us